Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP...
-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 03, 2022 1:44pm
Hemostemix Inc. $HMTXF stock evaluation
Hemostemix Inc. (OTC: $HMTXF) is a clinical-stage biotech company listed over OTC, having a market cap of 16.27M. It started at an open share price of $0.2474+ The stock analysis of 52 weeks is marked
...more
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 03, 2022 1:37pm
Hemostemix Inc.'s $HMTXF market cap has broadened.
Hemostemix Inc. (OTC: $HMTXF) is an excellent stock to hold on to as the company is on the verge of completing the phase II clinical trial of its lead product ACP-01 in the United States. The company
...more
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 03, 2022 12:09pm
$HMTXF Hemostemix Inc's current share price
Hemostemix Inc. (OTC: $HMTXF) has an overall market cap of 16.27M with an average volume estimation of 30-days 17,677. The total listed share outstanding sized up as 68.25M.
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 02, 2022 11:43am
Hemostemix informs regarding non-brokered private placement
Hemostemix Inc. announces a non-brokered private placement of up to 15 Million Units priced in the context of the market. https://www.newsfilecorp.com/redirect/WrjBBuqKvY
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 02, 2022 11:32am
Hemostemix Inc. Market Awareness
Hemostemix is a clinical-stage biotechnology company trading in TSX-V with ticker symbol $HEM is currently sitting at $0.32 with volume of 1.10K+. https://money.tmx.com/en/quote/HEM
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 01, 2022 11:46am
$HMTXF will compensate finder’s fees with the proceeds money
Proceeds from the offering will be utilized to pay an 8% finder’s fee in connection with the closing and current filing and regulatory fees.
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 01, 2022 11:38am
$HMTXF common share and warrant meaning elaboration
The recently announced private placement of 15 million units has put the entire OTC in awe, in which each full unit consists of one common share and one purchase warrant, each full warrant entitles
...more
(4)
•••
JocetooBad
X
View Profile
View Bullboard History
Comment by
JocetooBad
on Jun 01, 2022 11:17am
RE:Hemostemix $HEM
Thanks Captain Obvious! Are you a chatbot?!
(13)
•••
trade007
X
View Profile
View Bullboard History
Post by
trade007
on Jun 01, 2022 10:21am
Hemostemix $HEM
Hemostemix is one of the first clinical-stage biotech companies dealing with stem cell therapy and testing with the multi-center Phase II clinical trial for patients with critical limb ischemia ("
...more
(13)
•••
trade007
X
View Profile
View Bullboard History
Post by
trade007
on Jun 01, 2022 10:16am
$HEM to hold a classified financial sum with Aspire
Hemostemix is focused on offering a financial total to Aspire Health Science. In the wake of shutting the settlement agreement, Aspire will return all the clinical trial information and the licensed
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 01, 2022 10:16am
TSX-V listed $HEM today's stock stats
The market is currently moving with $0.32 each share offering and has obtained 10.36 K volumes. Also, check out the other top listed stocks $PQE on TSX-V itself. https://money.tmx.com/en/quote
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 01, 2022 9:46am
$HEM sellers still lead
The sell-out ratio keeps increasing than the buyout score; people keep selling to fill their pockets with a huge profit on the price. Also have a look at $PQE listed on TSX-V aswell. https
...more
(13)
•••
trade007
X
View Profile
View Bullboard History
Post by
trade007
on May 31, 2022 11:40am
$HEM- The Future of Medicine
Hemostemix believes our bodies can be an abundant source of our own treatments. Also, they believe that Hemostemix can shape the eventual fate of medication by conveying regenerative meds that are
...more
(7)
•••
TRADERCONNECTS
X
View Profile
View Bullboard History
Post by
TRADERCONNECTS
on May 30, 2022 2:22pm
$HEM got two new members in the group
$HEM got two new members in the group. Click on the link to view the news release. https://www.newsfilecorp.com/redirect/zWneph7r17
(3)
•••
tradeviewww
X
View Profile
View Bullboard History
Post by
tradeviewww
on May 30, 2022 1:59pm
The previous closure was $0.33 and initiated the new offer
The previous closure was $0.33 and initiated the new offering. Follow the link below to learn more. https://money.tmx.com/en/quote/HEM
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >